A new approach to treating sleep disorders? - Medical marijuana review
DOI:
https://doi.org/10.12775/JEHS.2024.65.003Keywords
Medical Marijuana, Insomnia, Sleep DisordersAbstract
Insomnia, defined as difficulty falling or staying asleep, significantly impacts the quality of life and mental health of people worldwide. In recent years, there has been growing interest in using medical marijuana as an alternative treatment method for various conditions, including sleep disorders. The purpose of this review is to examine the available scientific evidence regarding the efficacy and safety of using medical marijuana in the treatment of insomnia. Analyzing data from clinical, observational, and experimental studies, this work aims to present a comprehensive picture of the potential benefits and risks associated with such treatment. This review seeks to provide doctors, patients, and policymakers with up-to-date information that can support the decision-making process regarding the use of medical marijuana as an adjunct therapy in the treatment of insomnia, highlighting both the therapeutic potential and the need for further research in this field.
References
Roth T. Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med. 2007;3(5 Suppl):S7-S10. doi:10.5664/jcsm.26929. PMID: 17824495; PMCID: PMC1978319.
Levenson JC, Kay DB, Buysse DJ. The pathophysiology of insomnia. Chest. 2015;147(4):1179-1192. doi:10.1378/chest.14-1617. PMID: 25846534; PMCID: PMC4388122.
Kaur H, Spurling BC, Bollu PC. Chronic Insomnia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. PMID: 30252392.
Hertenstein E, Benz F, Schneider CL, et al. Insomnia-A risk factor for mental disorders. J Sleep Res. 2023;32(6):e13930. doi:10.1111/jsr.13930. PMID: 37211915.
Sivertsen B, Lallukka T, Salo P, et al. Insomnia as a risk factor for ill health: results from the large population-based prospective HUNT Study in Norway. J Sleep Res. 2014;23(2):124-132. doi:10.1111/jsr.12102. PMID: 24635564.
ICD-10-CM Codes G00-G99. Available from: https://www.icd10data.com/ICD10CM/Codes/G00-G99/G40-G47/G47-/G47.00.
Lie JD, Tu KN, Shen DD, Wong BM. Pharmacological Treatment of Insomnia. P T. 2015;40(11):759-771. PMID: 26609210; PMCID: PMC4634348.
Turner AR, Patel P, Agrawal S. Marijuana. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. Updated 2024 Feb 2.
Amin MR, Ali DW. Pharmacology of Medical Cannabis. Adv Exp Med Biol. 2019;1162:151-165. doi:10.1007/978-3-030-21737-2_8. PMID: 31332738.
VanDolah HJ, Bauer BA, Mauck KF. Clinicians' Guide to Cannabidiol and Hemp Oils. Mayo Clin Proc. 2019;94(9):1840-1851. doi:10.1016/j.mayocp.2019.01.003. PMID: 31447137.
Cinti S. Medical marijuana in HIV-positive patients: what do we know? J Int Assoc Physicians AIDS Care (Chic). 2009;8(6):342-346. doi:10.1177/1545109709351167. PMID: 19952287.
Urits I, Charipova K, Gress K, et al. Adverse Effects of Recreational and Medical Cannabis. Psychopharmacol Bull. 2021;51(1):94-109. PMID: 33897066; PMCID: PMC8063125.
Wang T, Collet JP, Shapiro S, Ware MA. Adverse effects of medical cannabinoids: a systematic review. CMAJ. 2008;178(13):1669-1678. doi:10.1503/cmaj.071178. PMID: 18559804; PMCID: PMC2413308.
Rehman Y, Saini A, Huang S, et al. Cannabis in the management of PTSD: a systematic review. AIMS Neurosci. 2021;8(3):414-434. doi:10.3934/Neuroscience.2021022. PMID: 34183989; PMCID: PMC8222769.
Doyle A, Harvey J. Cannabis and Epilepsy. J Dual Diagn. 2020;16(1):75-82. doi:10.1080/15504263.2019.1645372. PMID: 31385740.
Van Ameringen M, Zhang J, Patterson B, Turna J. The role of cannabis in treating anxiety: an update. Curr Opin Psychiatry. 2020;33(1):1-7. doi:10.1097/YCO.0000000000000566. PMID: 31688192.
Mangoo S, Erridge S, Holvey C, et al. Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry. Expert Rev Neurother. 2022;22(11-12):995-1008. doi:10.1080/14737175.2022.2161894. PMID: 36573268.
Graczyk M, Lewandowska AA, Melnyczok P, et al. Cannabinoids-Perspectives for Individual Treatment in Selected Patients: Analysis of the Case Series. Biomedicines. 2022;10(8):1862. doi:10.3390/biomedicines10081862. PMID: 36009411; PMCID: PMC9405173.
Litt MD, Kadden RM, Tennen H, et al. Individualized assessment and treatment program (IATP) for cannabis use disorder: Randomized controlled trial with and without contingency management. Psychol Addict Behav. 2020;34(1):40-51. doi:10.1037/adb0000491. PMID: 31318225; PMCID: PMC6980271.
Walsh JH, Maddison KJ, Rankin T, et al. Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo. Sleep. 2021;44(11):zsab149. doi:10.1093/sleep/zsab149. PMID: 34115851; PMCID: PMC8598183.
Ried K, Tamanna T, Matthews S, et al. Medicinal cannabis improves sleep in adults with insomnia: a randomised double-blind placebo-controlled crossover study. J Sleep Res. 2023;32(3):e13793. doi:10.1111/jsr.13793. PMID: 36539991.
Vigil JM, Stith SS, Diviant JP, et al. Effectiveness of Raw, Natural Medical Cannabis Flower for Treating Insomnia under Naturalistic Conditions. Medicines (Basel). 2018;5(3):75. doi:10.3390/medicines5030075. PMID: 29997343; PMCID: PMC6164964.
Sznitman SR, Vulfsons S, Meiri D, et al. Medical cannabis and insomnia in older adults with chronic pain: a cross-sectional study. BMJ Support Palliat Care. 2020;10(4):415-420. doi:10.1136/bmjspcare-2019-001938. PMID: 31959585.
Altman BR, Mian MN, Slavin M, et al. Cannabis Expectancies for Sleep. J Psychoactive Drugs. 2019;51(5):405-412. doi:10.1080/02791072.2019.1643053. PMID: 31319769; PMCID: PMC10446891.
Skobic I, Apolinar GR, Quan SF, et al. Marijuana versus evidence-based treatments for sleep and relaxation: A cross-sectional study of use and dose modification following involuntary job loss. Sleep Health. 2021;7(1):113-117. doi:10.1016/j.sleh.2020.06.008. PMID: 32758411; PMCID: PMC7855254.
Gilman JM, Schuster RM, Potter KW, et al. Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(3):e222106. doi:10.1001/jamanetworkopen.2022.2106. PMID: 35302633; PMCID: PMC8933735.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71. PMID: 33782057; PMCID: PMC8005924.
Perlman AI, McLeod HM, Ventresca EC, et al. Medical Cannabis State and Federal Regulations: Implications for United States Health Care Entities. Mayo Clin Proc. 2021;96(10):2671-2681. doi:10.1016/j.mayocp.2021.05.005. PMID: 34607636.
Vaillancourt R, Gallagher S, Cameron JD, et al. Cannabis use in patients with insomnia and sleep disorders: Retrospective chart review. Can Pharm J (Ott). 2022;155(3):175-180. doi:10.1177/17151635221089617. PMID: 35519083; PMCID:PMC9067069.
Velzeboer R, Malas A, Boerkoel P, et al. Cannabis dosing and administration for sleep: a systematic review. Sleep. 2022;45(11):zsac218. doi:10.1093/sleep/zsac218. PMID: 36107800.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Daniel Gondko, Patrycja Dębiec, Jakub Roman, Nikodem Pietrzak
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 452
Number of citations: 0
